News | January 29, 2024
Jubilant Pharmova Singapore to sell its entire 25.8% stake in Sofie Biosciences, USA
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
Innovent will supply sintilimab for the collaborated clinical trial
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
Subscribe To Our Newsletter & Stay Updated
